Episode Details

Back to Episodes

Lorlatinib shows unprecedented success in advanced NSCLC

Episode 363 Published 2 years, 2 months ago
Description
Which drug keeps lung cancer from progressing for over 5 years? Find out about this and more in today's PeerDirect Medical News Podcast.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us